[1]
Katsiki N, Kouvari M, Panagiotakos DB, et al. The association between serum uric acid levels and 10-year cardiovascular disease inci-dence: results from the ATTICA prospective study. Rev Cardiovasc Med 2021; 22(3): 991-1001.
[http://dx.doi.org/10.31083/j.rcm2203108] [PMID: 34565100]
[http://dx.doi.org/10.31083/j.rcm2203108] [PMID: 34565100]
[2]
Drivelegka P, Forsblad-d’Elia H, Angerås O, et al. Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot. Arthritis Res Ther 2020; 22(1): 37.
[http://dx.doi.org/10.1186/s13075-020-2119-0] [PMID: 32087742]
[http://dx.doi.org/10.1186/s13075-020-2119-0] [PMID: 32087742]
[3]
Richette P, Doherty M, Pascual E, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis 2020; 79(1): 31-8.
[http://dx.doi.org/10.1136/annrheumdis-2019-215315] [PMID: 31167758]
[http://dx.doi.org/10.1136/annrheumdis-2019-215315] [PMID: 31167758]
[4]
Daskalopoulou S, Tzovaras V, Mikhailidis D, Elisaf M. Effect on serum uric acid levels of drugs prescribed for indications other than treat-ing hyperuricaemia. Curr Pharm Des 2005; 11(32): 4161-75.
[http://dx.doi.org/10.2174/138161205774913309] [PMID: 16375738]
[http://dx.doi.org/10.2174/138161205774913309] [PMID: 16375738]
[5]
Cipolletta E, Tata LJ, Nakafero G, Avery AJ, Mamas MA, Abhishek A. Association between gout flare and subsequent cardiovascular events among patients with gout. JAMA 2022; 328(5): 440-50.
[http://dx.doi.org/10.1001/jama.2022.11390] [PMID: 35916846]
[http://dx.doi.org/10.1001/jama.2022.11390] [PMID: 35916846]
[6]
Hammer HB, Rollefstad S, Semb AG, et al. Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study. RMD Open 2022; 8(2): e002348.
[http://dx.doi.org/10.1136/rmdopen-2022-002348] [PMID: 35863863]
[http://dx.doi.org/10.1136/rmdopen-2022-002348] [PMID: 35863863]
[7]
Calabuig I, Martínez-Sanchis A, Andrés M. Sonographic tophi and inflammation are associated with carotid atheroma plaques in gout. Front Med (Lausanne) 2021; 8: 795984.
[http://dx.doi.org/10.3389/fmed.2021.795984] [PMID: 34977097]
[http://dx.doi.org/10.3389/fmed.2021.795984] [PMID: 34977097]
[8]
Wang P, Smith SE, Garg R, et al. Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT. RMD Open 2018; 4(1): e000593.
[http://dx.doi.org/10.1136/rmdopen-2017-000593] [PMID: 29556417]
[http://dx.doi.org/10.1136/rmdopen-2017-000593] [PMID: 29556417]
[9]
Diaz-Torne C, Ortiz MA, Garcia-Guillen A, et al. The inflammatory role of silent urate crystal deposition in intercritical gout. Rheumatology (Oxford) 2021; 60(11): 5463-72.
[http://dx.doi.org/10.1093/rheumatology/keab335] [PMID: 33839783]
[http://dx.doi.org/10.1093/rheumatology/keab335] [PMID: 33839783]
[10]
Estevez-Garcia IO, Gallegos-Nava S, Vera-Pérez E, et al. Levels of cytokines and micro RNAs in individuals with asymptomatic hyperu-ricemia and ultrasonographic findings of gout: A bench‐to‐bedside approach. Arthritis Care Res (Hoboken) 2018; 70(12): 1814-21.
[http://dx.doi.org/10.1002/acr.23549] [PMID: 29457379]
[http://dx.doi.org/10.1002/acr.23549] [PMID: 29457379]
[11]
Toprover M, Shah B, Oh C, et al. Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces inter-critical inflammation: a prospective observational study. Arthritis Res Ther 2020; 22(1): 169.
[http://dx.doi.org/10.1186/s13075-020-02260-6] [PMID: 32653044]
[http://dx.doi.org/10.1186/s13075-020-02260-6] [PMID: 32653044]